Global Technology – January 2016

According to the journal Aging, Salk Institute researchers have found that an experimental drug candidate intended to combat Alzheimer’s disease produces a host of anti-aging effects, as well.

The Salk team expanded upon their previous development of a drug candidate, called J147. In the new work, the team showed that the drug works well in a mouse model of aging not typically used in Alzheimer’s research.

When the mice were treated with J147, they demonstrated better memory and cognition, healthier blood vessels in the br.....

This content is for BUSINESS BRIEFINGS members only.